Zymeworks Inc. Analysts Are Reducing Their Forecasts For Next Year

ZYME Stock  USD 13.40  0.06  0.45%   
About 54% of Zymeworks Common's investor base is interested to short. The analysis of the overall investor sentiment regarding Zymeworks Common Stock suggests that many traders are impartial. The current market sentiment, together with Zymeworks Common's historical and current headlines, can help investors time the market. In addition, many technical investors use Zymeworks Common Stock stock news signals to limit their universe of possible portfolio assets.
  
Today is shaping up negative for Zymeworks Inc. shareholders, with the analysts delivering a...

Read at finance.yahoo.com
Yahoo News
  

Zymeworks Common Fundamental Analysis

We analyze Zymeworks Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zymeworks Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zymeworks Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Zymeworks Common is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Zymeworks Common Stock Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zymeworks Common stock to make a market-neutral strategy. Peer analysis of Zymeworks Common could also be used in its relative valuation, which is a method of valuing Zymeworks Common by comparing valuation metrics with similar companies.

Peers

Zymeworks Common Related Equities

BLUEBluebird Bio   7.37   
0%
100.0%
BPMCBlueprint Medicines   6.80   
0%
92.0%
ANNXAnnexon   5.60   
0%
75.0%
RLAYRelay Therapeutics   4.92   
0%
66.0%
EDITEditas Medicine   4.92   
0%
66.0%
RVMDRevolution Medicines   4.25   
0%
57.0%
MRSNMersana Therapeutics   4.00   
0%
54.0%
TVTXTravere Therapeutics   3.68   
0%
49.0%
PTGXProtagonist Therapeutics   3.44   
0%
46.0%
AKROAkero Therapeutics   2.87   
0%
38.0%
YMABY MAbs   2.58   
0%
35.0%
ZNTLZentalis Pharmaceuticals   2.48   
0%
33.0%
SNDXSyndax Pharmaceuticals   2.36   
0%
32.0%
ARWRArrowhead Pharmaceuticals   0.16   
2.0%
0%
PRQRProQR Therapeutics   0.43   
5.0%
0%
INZYInozyme Pharma   0.83   
11.0%
0%
ALECAlector   1.20   
16.0%
0%
STOKStoke Therapeutics   1.75   
23.0%
0%
TERNTerns Pharmaceuticals   1.86   
25.0%
0%
CYTKCytokinetics   3.06   
41.0%
0%
APLSApellis Pharmaceuticals   3.27   
44.0%
0%
DAWNDay One   4.03   
54.0%
0%
CABACabaletta Bio   4.23   
57.0%
0%

Complementary Tools for Zymeworks Stock analysis

When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios